BMJ 1996;313:711-715 (21 September)

Papers

Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study

D J Hole, principal epidemiologist,a G C M Watt, professor,b G Davey-Smith, professor,c C L Hart, senior statistician,a C R Gillis, director,a V M Hawthorne, professor d

a West of Scotland Cancer Surveillance Unit, Ruchill Hospital, Glasgow G20 9NB, b Department of General Practice, University of Glasgow, Glasgow, c Department of Social Medicine, University of Bristol, Bristol, d Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA

Correspondence to: Dr Hole.

Abstract

Objective: To assess the relation between forced expiratory volume in one second (FEV1) and subsequent mortality.
Design: Prospective general population study.
Setting: Renfrew and Paisley, Scotland.
Subjects: 7058 men and 8353 women aged 45-64 years at baseline screening in 1972-6.
Main outcome measure: Mortality from all causes, ischaemic heart disease, cancer, lung and other cancers, stroke, respiratory disease, and other causes of death after 15 years of follow up.
Results: 2545 men and 1894 women died during the follow up period. Significant trends of increasing risk with diminishing FEV1 are apparent for both sexes for all the causes of death examined after adjustment for age, cigarette smoking, diastolic blood pressure, cholesterol concentration, body mass index, and social class. The relative hazard ratios for all cause mortality for subjects in the lowest fifth of the FEV1 distribution were 1.92 (95% confidence interval 1.68 to 2.20) for men and 1.89 (1.63 to 2.20) for women. Corresponding relative hazard ratios were 1.56 (1.26 to 1.92) and 1.88 (1.44 to 2.47) for ischaemic heart disease, 2.53 (1.69 to 3.79) and 4.37 (1.84 to 10.42) for lung cancer, and 1.66 (1.07 to 2.59) and 1.65 (1.09 to 2.49) for stroke. Reduced FEV1 was also associated with an increased risk for each cause of death examined except cancer for lifelong nonsmokers.
Conclusions: Impaired lung function is a major clinical indicator of mortality risk in men and women for a wide range of diseases. The use of FEV1 as part of any health assessment of middle aged patients should be considered. Smokers with reduced FEV1 should form a priority group for targeted advice to stop smoking.

Key messages

  • These increased risks, with the exception of the cancers, are apparent for lifelong non-smokers

  • FEV1 is second in importance to cigarette smoking as a predictor of subsequent all cause mortality and is as important as cholesterol in predicting mortality from ischaemic heart disease

  • FEV1 should be included in health assessment of middle aged men and women

  • Smokers with a reduced FEV1 should be targeted with advice to stop smoking


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Effect of tobacco smoking on survival of men and women by social position: a 28 year cohort study
Laurence Gruer, Carole L Hart, David S Gordon, and Graham C M Watt
BMJ 2009 338: b480. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Sunyer, J., Forastiere, F., Pekkanen, J., Plana, E., Kolz, M., Pistelli, R., Jacquemin, B., Bruske-Hohlfeld, I., Pitsavos, Ch., Bellander, T., Koenig, W., Peters, A., on behalf of the AIRGENE Study Group, (2009). Interaction between smoking and the interleukin-6 gene affects systemic levels of inflammatory biomarkers. Nicotine Tob Res 11: 1347-1353 [Abstract] [Full text]  
  • van Gestel, Y R B M, Hoeks, S E, Sin, D D, Huzeir, V, Stam, H, Mertens, F W, van Domburg, R T, Bax, J J, Poldermans, D (2009). COPD and cancer mortality: the influence of statins. Thorax 64: 963-967 [Abstract] [Full text]  
  • Maclay, J. D., McAllister, D. A., Mills, N. L., Paterson, F. P., Ludlam, C. A., Drost, E. M., Newby, D. E., MacNee, W. (2009). Vascular Dysfunction in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 180: 513-520 [Abstract] [Full text]  
  • Lange, N. E., Mulholland, M., Kreider, M. E. (2009). Spirometry: Don't Blow It!. Chest 136: 608-614 [Abstract] [Full text]  
  • Ferrie, J E, Singh-Manoux, A, Kivimaki, M, Mindell, J, Breeze, E, Smith, G D., Shipley, M J (2009). Cardiorespiratory risk factors as predictors of 40-year mortality in women and men. Heart 95: 1250-1257 [Abstract] [Full text]  
  • Young, R P, Hopkins, R, Eaton, T E (2009). Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence. Postgrad. Med. J. 85: 414-421 [Abstract] [Full text]  
  • Engstrom, G., Gerhardsson de Verdier, M., Dahlback, M., Janson, C., Lind, L. (2009). BP Variability and Cardiovascular Autonomic Function in Relation to Forced Expiratory Volume: A Population-Based Study. Chest 136: 177-183 [Abstract] [Full text]  
  • Lee, H. M., Chung, S. J., Lopez, V. A., Wong, N. D. (2009). Association of FVC and Total Mortality in US Adults With Metabolic Syndrome and Diabetes. Chest 136: 171-176 [Abstract] [Full text]  
  • Dawkins, P. A., Dawkins, C. L., Wood, A. M., Nightingale, P. G., Stockley, J. A., Stockley, R. A. (2009). Rate of progression of lung function impairment in {alpha}1-antitrypsin deficiency. Eur Respir J 33: 1338-1344 [Abstract] [Full text]  
  • Bolton, C. E, Cockcroft, J. R, Sabit, R., Munnery, M., McEniery, C. M, Wilkinson, I. B, Ebrahim, S., Gallacher, J. E, Shale, D. J, Ben-Shlomo, Y. (2009). Lung function in mid-life compared with later life is a stronger predictor of arterial stiffness in men: The Caerphilly Prospective Study. Int J Epidemiol 38: 867-876 [Abstract] [Full text]  
  • Fullerton, D., Britton, J. R, Lewis, S. A, Pavord, I. D, McKeever, T. M, Fogarty, A. W (2009). Helicobacter pylori and lung function, asthma, atopy and allergic disease--A population-based cross-sectional study in adults. Int J Epidemiol 38: 419-426 [Abstract] [Full text]  
  • Leone, N., Courbon, D., Thomas, F., Bean, K., Jego, B., Leynaert, B., Guize, L., Zureik, M. (2009). Lung Function Impairment and Metabolic Syndrome: The Critical Role of Abdominal Obesity. Am. J. Respir. Crit. Care Med. 179: 509-516 [Abstract] [Full text]  
  • Ueda, K., Tanaka, T., Li, T.-S., Tanaka, N., Hamano, K. (2009). Quantitative computed tomography for the prediction of pulmonary function after lung cancer surgery: a simple method using simulation software. Eur. J. Cardiothorac. Surg. 35: 414-418 [Abstract] [Full text]  
  • Brown, T. (2009). Silica exposure, smoking, silicosis and lung cancer--complex interactions. Occup Med (Lond) 59: 89-95 [Abstract] [Full text]  
  • Hancox, R J, Poulton, R, Greene, J M, McLachlan, C R, Pearce, M S, Sears, M R (2009). Associations between birth weight, early childhood weight gain and adult lung function. Thorax 64: 228-232 [Abstract] [Full text]  
  • Gruer, L., Hart, C. L, Gordon, D. S, Watt, G. C M (2009). Effect of tobacco smoking on survival of men and women by social position: a 28 year cohort study. BMJ 338: b480-b480 [Abstract] [Full text]  
  • Iwamoto, H., Yokoyama, A., Kitahara, Y., Ishikawa, N., Haruta, Y., Yamane, K., Hattori, N., Hara, H., Kohno, N. (2009). Airflow Limitation in Smokers Is Associated with Subclinical Atherosclerosis. Am. J. Respir. Crit. Care Med. 179: 35-40 [Abstract] [Full text]  
  • Gerhardsson de Verdier, M. (2008). The Big Three Concept: A Way to Tackle the Health Care Crisis?. Proc Am Thorac Soc 5: 800-805 [Abstract] [Full text]  
  • MacNee, W., Maclay, J., McAllister, D. (2008). Cardiovascular Injury and Repair in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 5: 824-833 [Abstract] [Full text]  
  • Franssen, F M E, O'Donnell, D E, Goossens, G H, Blaak, E E, Schols, A M W J (2008). Obesity and the lung: 5 {middle dot} Obesity and COPD. Thorax 63: 1110-1117 [Abstract] [Full text]  
  • Alexeeff, S E, Litonjua, A A, Wright, R O, Baccarelli, A, Suh, H, Sparrow, D, Vokonas, P S, Schwartz, J (2008). Ozone exposure, antioxidant genes, and lung function in an elderly cohort: VA normative aging study. Occup. Environ. Med. 65: 736-742 [Abstract] [Full text]  
  • Song, Y.-M., Sung, J., Ha, M. (2008). Obesity and Risk of Cancer in Postmenopausal Korean Women. JCO 26: 3395-3402 [Abstract] [Full text]  
  • Moro, L., Pedone, C., Scarlata, S., Malafarina, V., Fimognari, F., Antonelli-Incalzi, R. (2008). Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease. ANGIOLOGY 59: 357-364 [Abstract]  
  • McClean, K M, Kee, F, Young, I S, Elborn, J S (2008). Obesity and the lung: 1 {middle dot} Epidemiology. Thorax 63: 649-654 [Abstract] [Full text]  
  • Subbarao, P., Sears, M. R (2008). The chicken or the egg? Perhaps the egg. Arch. Dis. Child. 93: 552-553 [Full text]  
  • Hart, C., McConnachie, A., Upton, M., Watt, G. (2008). Risk factors in the Midspan family study by social class in childhood and adulthood. Int J Epidemiol 37: 604-614 [Abstract] [Full text]  
  • Chatila, W. M., Thomashow, B. M., Minai, O. A., Criner, G. J., Make, B. J. (2008). Comorbidities in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 5: 549-555 [Abstract] [Full text]  
  • Galobardes, B, McCarron, P, Jeffreys, M, Davey Smith, G (2008). Association between early life history of respiratory disease and morbidity and mortality in adulthood. Thorax 63: 423-429 [Abstract] [Full text]  
  • Brekke, P. H., Omland, T., Holmedal, S. H., Smith, P., Soyseth, V. (2008). Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation. Eur Respir J 31: 563-570 [Abstract] [Full text]  
  • Poulain, M., Doucet, M., Drapeau, V., Fournier, G., Tremblay, A., Poirier, P., Maltais, F. (2008). Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease. Chronic Respiratory Disease 5: 35-41 [Abstract]  
  • Smith, C.J.P., Gribbin, J., Challen, K.B., Hubbard, R.B. (2008). The impact of the 2004 NICE guideline and 2003 General Medical Services contract on COPD in primary care in the UK. QJM 101: 145-153 [Abstract] [Full text]  
  • Fabbri, L. M., Luppi, F., Beghe, B., Rabe, K. F. (2008). Complex chronic comorbidities of COPD. Eur Respir J 31: 204-212 [Abstract] [Full text]  
  • Sabit, R., Shale, D. J. (2007). Vascular Structure and Function in Chronic Obstructive Pulmonary Disease: A Chicken and Egg Issue?. Am. J. Respir. Crit. Care Med. 176: 1175-1176 [Full text]  
  • McAllister, D. A., Maclay, J. D., Mills, N. L., Mair, G., Miller, J., Anderson, D., Newby, D. E., Murchison, J. T., MacNee, W. (2007). Arterial Stiffness Is Independently Associated with Emphysema Severity in Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 176: 1208-1214 [Abstract] [Full text]  
  • Downs, S. H., Schindler, C., Liu, L.-J. S., Keidel, D., Bayer-Oglesby, L., Brutsche, M. H., Gerbase, M. W., Keller, R., Kunzli, N., Leuenberger, P., Probst-Hensch, N. M., Tschopp, J.-M., Zellweger, J.-P., Rochat, T., Schwartz, J., Ackermann-Liebrich, U., the SAPALDIA Team, (2007). Reduced Exposure to PM10 and Attenuated Age-Related Decline in Lung Function. NEJM 357: 2338-2347 [Abstract] [Full text]  
  • Sin, D. D., Greaves, L., Kennedy, S. (2007). The Tip of the "ICEBERGS": A National Conference to Combat the Growing Global Epidemic of COPD in Women. Proc Am Thorac Soc 4: 669-670 [Full text]  
  • Zhai, G., Valdes, A. M., Cherkas, L., Clement, G., Strachan, D., Spector, T. D. (2007). The Interaction of Genes and Smoking on Forced Expiratory Volume: A Classic Twin Study. Chest 132: 1772-1777 [Abstract] [Full text]  
  • Hegewald, M. J., Crapo, R. O. (2007). Socioeconomic Status and Lung Function. Chest 132: 1608-1614 [Abstract] [Full text]  
  • Young, R. P., Hopkins, R., Eaton, T. E. (2007). Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J 30: 616-622 [Abstract] [Full text]  
  • Bellia, V., Pedone, C., Catalano, F., Zito, A., Davi, E., Palange, S., Forastiere, F., Incalzi, R. A. (2007). Asthma in the Elderly: Mortality Rate and Associated Risk Factors for Mortality. Chest 132: 1175-1182 [Abstract] [Full text]  
  • Rennard, S. I. (2007). Inflammation in COPD: a link to systemic comorbidities. ERR 16: 91-97 [Abstract] [Full text]  
  • Fimognari, F. L., Pasqualetti, P., Moro, L., Franco, A., Piccirillo, G., Pastorelli, R., Rossini, P. M., Incalzi, R. A. (2007). The Association Between Metabolic Syndrome and Restrictive Ventilatory Dysfunction in Older Persons. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 62: 760-765 [Abstract] [Full text]  
  • Sabit, R., Bolton, C. E., Edwards, P. H., Pettit, R. J., Evans, W. D., McEniery, C. M., Wilkinson, I. B., Cockcroft, J. R., Shale, D. J. (2007). Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 175: 1259-1265 [Abstract] [Full text]  
  • Fogarty, A. W, Jones, S., Britton, J. R, Lewis, S. A, McKeever, T. M (2007). Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 62: 515-520 [Abstract] [Full text]  
  • Hart, C. L, Hole, D. J, Lawlor, D. A, Davey Smith, G., Lever, T. F (2007). Effect of conjugal bereavement on mortality of the bereaved spouse in participants of the Renfrew/Paisley Study. J. Epidemiol. Community Health 61: 455-460 [Abstract] [Full text]  
  • Rudolf, M. (2007). COPD and death: what exactly is the relationship?. Thorax 62: 378-379 [Full text]  
  • Soyseth, V., Brekke, P. H., Smith, P., Omland, T. (2007). Statin use is associated with reduced mortality in COPD. Eur Respir J 29: 279-283 [Abstract] [Full text]  
  • Le Jemtel, T. H., Padeletti, M., Jelic, S. (2007). Diagnostic and Therapeutic Challenges in Patients With Coexistent Chronic Obstructive Pulmonary Disease and Chronic Heart Failure. J Am Coll Cardiol 49: 171-180 [Abstract] [Full text]  
  • Purdue, M. P, Gold, L., Jarvholm, B., Alavanja, M. C R, Ward, M. H, Vermeulen, R. (2007). Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers. Thorax 62: 51-56 [Abstract] [Full text]  
  • Sin, D. D., Anthonisen, N. R., Soriano, J. B., Agusti, A. G. (2006). Mortality in COPD: role of comorbidities. Eur Respir J 28: 1245-1257 [Abstract] [Full text]  
  • Stewart, S., Murphy, N.F., McMurray, J.J.V., Jhund, P., Hart, C.L., Hole, D. (2006). Effect of socioeconomic deprivation on the population risk of incident heart failure hospitalisation: An analysis of the Renfrew/Paisley Study. Eur J Heart Fail 8: 856-863 [Abstract] [Full text]  
  • Ueda, K., Jinbo, M., Li, T.-S., Yagi, T., Suga, K., Hamano, K. (2006). Computed Tomography-Diagnosed Emphysema, Not Airway Obstruction, Is Associated with the Prognostic Outcome of Early-Stage Lung Cancer.. Clin. Cancer Res. 12: 6730-6736 [Abstract] [Full text]  
  • Frostad, A, Soyseth, V, Haldorsen, T, Andersen, A, Gulsvik, A (2006). Respiratory symptoms and 30 year mortality from obstructive lung disease and pneumonia. Thorax 61: 951-956 [Abstract] [Full text]  
  • Aronson, D., Roterman, I., Yigla, M., Kerner, A., Avizohar, O., Sella, R., Bartha, P., Levy, Y., Markiewicz, W. (2006). Inverse Association between Pulmonary Function and C-Reactive Protein in Apparently Healthy Subjects. Am. J. Respir. Crit. Care Med. 174: 626-632 [Abstract] [Full text]  
  • Pembroke, T. P I, Rasul, F., Hart, C. L, Davey Smith, G., Stansfeld, S. A (2006). Psychological distress and chronic obstructive pulmonary disease in the Renfrew and Paisley (MIDSPAN) study.. J. Epidemiol. Community Health 60: 789-792 [Abstract] [Full text]  
  • Sin, D. D., Man, S. F. P. (2006). Pharmacotherapy for Mortality Reduction in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 3: 624-629 [Abstract] [Full text]  
  • Machado, M.-C. L., Krishnan, J. A., Buist, S. A., Bilderback, A. L., Fazolo, G. P., Santarosa, M. G., Queiroga, F. Jr., Vollmer, W. M. (2006). Sex Differences in Survival of Oxygen-dependent Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 174: 524-529 [Abstract] [Full text]  
  • Stavem, K., Sandvik, L., Erikssen, J. (2006). Can Global Initiative for Chronic Obstructive Lung Disease Stage 0 Provide Prognostic Information on Long-term Mortality in Men?. Chest 130: 318-325 [Abstract] [Full text]  
  • Gauderman, W. J. (2006). Air pollution and children--an unhealthy mix.. NEJM 355: 78-79 [Full text]  
  • Mancini, G.B. J., Etminan, M., Zhang, B., Levesque, L. E., FitzGerald, J. M., Brophy, J. M. (2006). Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary Disease. J Am Coll Cardiol 47: 2554-2560 [Abstract] [Full text]  
  • Mannino, D M, Davis, K J (2006). Lung function decline and outcomes in an elderly population. Thorax 61: 472-477 [Abstract] [Full text]  
  • Poulain, M., Doucet, M., Major, G. C., Drapeau, V., Series, F., Boulet, L.-P., Tremblay, A., Maltais, F. (2006). The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies.. CMAJ 174: 1293-1299 [Abstract] [Full text]  
  • Mannino, D. M., Watt, G., Hole, D., Gillis, C., Hart, C., McConnachie, A., Davey Smith, G., Upton, M., Hawthorne, V., Sin, D. D., Man, S. F. P., Van Eeden, S., Mapel, D. W., Vestbo, J. (2006). The natural history of chronic obstructive pulmonary disease.. Eur Respir J 27: 627-643 [Full text]  
  • Schottenfeld, D., Beebe-Dimmer, J. (2006). Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.. CA Cancer J Clin 56: 69-83 [Abstract] [Full text]  
  • Hart, C L, Davey Smith, G, Hole, D J, Hawthorne, V M (2006). Carboxyhaemoglobin concentration, smoking habit, and mortality in 25 years in the Renfrew/Paisley prospective cohort study. Heart 92: 321-324 [Abstract] [Full text]  
  • Murphy, N.F., MacIntyre, K., Stewart, S., Hart, C.L., Hole, D., McMurray, J.J.V. (2006). Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J 27: 96-106 [Abstract] [Full text]  
  • Pinto-Plata, V M, Mullerova, H, Toso, J F, Feudjo-Tepie, M, Soriano, J B, Vessey, R S, Celli, B R (2006). C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 61: 23-28 [Abstract] [Full text]  
  • Wannamethee, S G., Shaper, A G., Whincup, P. H (2005). Body fat distribution, body composition, and respiratory function in elderly men. Am. J. Clin. Nutr. 82: 996-1003 [Abstract] [Full text]  
  • Donaldson, G. C., Seemungal, T. A. R., Patel, I. S., Bhowmik, A., Wilkinson, T. M. A., Hurst, J. R., MacCallum, P. K., Wedzicha, J. A. (2005). Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD. Chest 128: 1995-2004 [Abstract] [Full text]  
  • Murray, A. D., Staff, R. T., Shenkin, S. D., Deary, I. J., Starr, J. M., Whalley, L. J. (2005). Brain White Matter Hyperintensities: Relative Importance of Vascular Risk Factors in Nondemented Elderly People. Radiology 237: 251-257 [Abstract] [Full text]  
  • Lawlor, D A, Ebrahim, S, Davey Smith, G (2005). Association of birth weight with adult lung function: findings from the British Women's Heart and Health Study and a meta-analysis. Thorax 60: 851-858 [Abstract] [Full text]  
  • Myint, P. K., Luben, R. N., Surtees, P. G., Wainwright, N. W. J., Welch, A. A., Bingham, S. A., Wareham, N. J., Day, N. E., Khaw, K-T. (2005). Respiratory function and self-reported functional health: EPIC-Norfolk population study. Eur Respir J 26: 494-502 [Abstract] [Full text]  
  • Hoogendoorn, M., Rutten-van Molken, M. P. M. H., Hoogenveen, R. T., van Genugten, M. L. L., Buist, A. S., Wouters, E. F. M., Feenstra, T. L. (2005). A dynamic population model of disease progression in COPD. Eur Respir J 26: 223-233 [Abstract] [Full text]  
  • Power, C., Hypponen, E., Davey Smith, G. (2005). Socioeconomic Position in Childhood and Early Adult Life and Risk of Mortality: A Prospective Study of the Mothers of the 1958 British Birth Cohort. AJPH 95: 1396-1402 [Abstract] [Full text]  
  • Richards, M., Strachan, D., Hardy, R., Kuh, D., Wadsworth, M. (2005). Lung Function and Cognitive Ability in a Longitudinal Birth Cohort Study. Psychosom. Med. 67: 602-608 [Abstract] [Full text]  
  • Wasswa-Kintu, S, Gan, W Q, Man, S F P, Pare, P D, Sin, D D (2005). Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 60: 570-575 [Abstract] [Full text]  
  • Fimognari, F L, Moro, L, Antonelli Incalzi, R, Sin, D D, Gan, W Q, Man, S F P, Senthilselvan, A (2005). COPD, restrictive syndrome and inflammation. Thorax 60: 612-613 [Full text]  
  • Sin, D. D., Wu, L., Man, S. F. P. (2005). The Relationship Between Reduced Lung Function and Cardiovascular Mortality: A Population-Based Study and a Systematic Review of the Literature. Chest 127: 1952-1959 [Abstract] [Full text]  
  • Sunyer, J., Ulrik, C. S. (2005). Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness?. Eur Respir J 25: 587-588 [Full text]  
  • Sin, D. D., Man, S. F. P. (2005). Can inhaled steroids mend a broken heart in chronic obstructive pulmonary disease?. Eur Respir J 25: 589-590 [Full text]  
  • Stavem, K., Aaser, E., Sandvik, L., Bjornholt, J. V., Erikssen, G., Thaulow, E., Erikssen, J. (2005). Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males. Eur Respir J 25: 618-625 [Abstract] [Full text]  
  • Sin, D. D., Man, S. F. P. (2005). Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality. Proc Am Thorac Soc 2: 8-11 [Abstract] [Full text]  
  • van Eeden, S. F., Yeung, A., Quinlam, K., Hogg, J. C. (2005). Systemic Response to Ambient Particulate Matter: Relevance to Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2: 61-67 [Abstract] [Full text]  
  • Man, S. F. P., Sin, D. D. (2005). Effects of Corticosteroids on Systemic Inflammation in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2: 78-82 [Abstract] [Full text]  
  • McKeever, T. M., Weston, P. J., Hubbard, R., Fogarty, A. (2005). Lung Function and Glucose Metabolism: An Analysis of Data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 161: 546-556 [Abstract] [Full text]  
  • Anthonisen, N. R., Skeans, M. A., Wise, R. A., Manfreda, J., Kanner, R. E., Connett, J. E., for the Lung Health Study Research Group*, (2005). The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality: A Randomized Clinical Trial. ANN INTERN MED 142: 233-239 [Abstract] [Full text]  
  • Gan, W. Q., Man, S.F. P., Sin, D. D. (2005). The Interactions Between Cigarette Smoking and Reduced Lung Function on Systemic Inflammation. Chest 127: 558-564 [Abstract] [Full text]  
  • Hart, C. L, MacKinnon, P. L, Watt, G. C., Upton, M. N, McConnachie, A., Hole, D. J, Smith, G. D., Gillis, C. R, Hawthorne, V. M (2005). The Midspan studies. Int J Epidemiol 34: 28-34 [Full text]  
  • van der Palen, J, Rea, T D, Manolio, T A, Lumley, T, Newman, A B, Tracy, R P, Enright, P L, Psaty, B M (2004). Respiratory muscle strength and the risk of incident cardiovascular events. Thorax 59: 1063-1067 [Abstract] [Full text]  
  • Wei, L., MacDonald, T. M., Walker, B. R. (2004). Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease. ANN INTERN MED 141: 764-770 [Abstract] [Full text]  
  • Kony, S, Zureik, M, Driss, F, Neukirch, C, Leynaert, B, Neukirch, F (2004). Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax 59: 892-896 [Abstract] [Full text]  
  • Sin, D. D., Lacy, P., York, E., Man, S. F. P. (2004). Effects of Fluticasone on Systemic Markers of Inflammation in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 170: 760-765 [Abstract] [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ